Drug discrimination in methamphetamine-trained rats: Effects of cholinergic nicotinic compounds

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 3, 2010, Pages 807-816

  Desai, Rajeev I ^a   Bergman, Jack ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABASEINE; ATROPINE; DEXAMPHETAMINE; DIHYDRO BETA ERYTHROIDINE; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; EPIBATIDINE; ISOARECOLONE; MECAMYLAMINE; METHAMPHETAMINE; METHYLLYCACONITINE; NICOTINE; RIVASTIGMINE; SCOPOLAMINE; UNCLASSIFIED DRUG; VARENICLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG TARGETING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; CONDITIONING, OPERANT; DEXTROAMPHETAMINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MECAMYLAMINE; METHAMPHETAMINE; MUSCARINIC ANTAGONISTS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PENTOBARBITAL; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY);

EID: 78649595753     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.173773     Document Type: Article

References (57)

1. Anderson DJ and Arneric SP (1994) Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain. Eur J Pharmacol 253:261-267.
2. Badio B and Daly JW (1994) Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 45:563-569. (Pubitemid 24139181)
3. Bechtholt AJ and Mark GP (2002) Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats. Psychopharmacology (Berl) 162:178-185.
4. Bednar I, Friberg L, and Nordberg A (2004) Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats. Neurochem Int 45:1049-1055. (Pubitemid 39164930)
5. Bergman J, Frasca J, Zakarian A, and Paronis CA (2006) Discriminative stimulus effects of adenosine antagonists in methamphetamine-trained monkeys, in Annual Meeting College on Problems of Drug Dependence; 2006 June 17-22; Scottsdale, AZ. Abstract 69, College on Problems of Drug Dependence, Philadelphia, PA.
6. Brioni JD, Kim DJ, and O'Neill AB (1996) Nicotine cue: lack of effect of the α7 nicotinic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1-5. (Pubitemid 26169734)
7. Cahill K, Stead LF, and Lancaster T (2007) Nicotine receptor partial agonists for smoking cessation. Cochrane Database System Review, CD006103, Cochrane Collaboration, London, UK.
8. Callahan PM, De La Garza R 2nd, and Cunningham KA (1997) Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601-607. (Pubitemid 27296769)
9. Czoty PW, Makriyannis A, and Bergman J (2004) Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology (Berl) 175:170-178. (Pubitemid 39222347)
10. Damaj MI, Creasy KR, Grove AD, Rosecrans JA, and Martin BR (1994) Pharmacological effects of epibatidine optical enantiomers. Brain Res 664:34-40.
11. Decker MW, Brioni JD, Bannon AW, and Arneric SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci 56:545-570.
12. Desai RI, Barber DJ, and Terry P (2003) Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology (Berl) 167:335-343.
13. Desai RI, Paronis CA, Martin J, Desai R, and Bergman J (2010) Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther 333:834-843.
14. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
15. Dwoskin LP, Buxton ST, Jewell AL, and Crooks PA (1993) S(-)-nornicotine increases dopamine release in a calcium-dependent manner from superfused rat striatal slices. J Neurochem 60:2167-2174.
16. Finney DJ (1964) Statistical Method in Biological Assay, 2nd ed, Hafner, New York.
17. Gatch MB, Flores E, and Forster MJ (2008) Nicotine and methamphetamine share discriminative stimulus effects. Drug Alcohol Depend 93:63-71. (Pubitemid 350236594)
18. Gerasimov MR, Franceschi M, Volkow ND, Rice O, Schiffer WK, and Dewey SL (2000) Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 38:432-437.
19. Glennon RA and Young R (1984) Further investigation of the discriminative stimulus properties of MDA. Pharmacol Biochem Behav 20:501-505. (Pubitemid 14138035)
20. Grady S, Marks MJ, Wonnacott S, and Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
21. Hahn B, Sharples CG, Wonnacott S, Shoaib M, and Stolerman IP (2003) Attentional effects of nicotinic agonists in rats. Neuropharmacology 44:1054-1067.
22. Heikkila RE, Orlansky H, Mytilineou C, and Cohen G (1975) Amphetamine: evaluation of D- and L-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J Pharmacol Exp Ther 194:47-56.
23. Hiranita T, Anggadiredja K, Fujisaki C, Watanabe S, and Yamamoto T (2004) Nicotine attenuates relapse to methamphetamine-seeking behavior (craving) in rats. Ann NY Acad Sci 1025:504-507.
24. Howell LL and Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196-217.
25. Järbe TU (1978) Cocaine as a discriminative cue in rats: interactions with neuroleptics and other drugs. Psychopharmacology (Berl) 59:183-187.
26. Jensen AA, Mikkelsen I, Frølund B, Bräuner-Osborne H, Falch E, and Krogsgaard-Larsen P (2003) Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors. Mol Pharmacol 64:865-875.
27. Kantak KM, Edwards MA, and Spealman RD (1995) Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists. J Pharmacol Exp Ther 274:657-665.
28. Karler R, Calder LD, and Bedingfield JB (1996) A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice. Brain Res 725:192-198. (Pubitemid 27377781)
29. Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3α-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288:302-315.
30. Kem WR, Mahnir VM, Papke RL, and Lingle CJ (1997) Anabaseine is a potent agonist on muscle and neuronal α-bungarotoxin-sensitive nicotinic receptors. J Pharmacol Exp Ther 283:979-992.
31. Kuczenski R and Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065.
32. Levin ED, Mead T, Rezvani AH, Rose JE, Gallivan C, and Gross R (2000) The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav 71:565-570.
33. Marks MJ, Robinson SF, and Collins AC (1996) Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 277:1383-1396.
34. Marks MJ, Stitzel JA, Romm E, Wehner JM, and Collins AC (1986) Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and α-bungarotoxin. Mol Pharmacol 30:427-436.
35. Mendelson JE, McGlothlin D, Harris DS, Foster E, Everhart T, Jacob P 3rd, and Jones RT (2008) The clinical pharmacology of intranasal l-methamphetamine. BMC Clin Pharmacol 8:4.
36. Mirza NR, Pei Q, Stolerman IP, and Zetterström TS (1996) The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens. Eur J Pharmacol 295:207-210.
37. Munzar P and Goldberg SR (2000) Dopaminergic involvement in the discriminative stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 148:209-216.
38. Reavill C, Jenner P, Kumar R, and Stolerman IP (1988) High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology 27:235-241.
39. Reavill C, Spivak CE, Stolerman IP, and Waters JA (1987) Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats. Neuropharmacology 26:789-792.
40. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, et al. (2007) Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985-994.
41. Rollema H, Shrikhande A, Ward KM, Tingley FD 3rd, Coe JW, O'Neill BT, Tseng E, Wang EQ, Mather RJ, Hurst RS, et al. (2010) Preclinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol 160:334-345.
42. Rothman RB and Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23-40.
43. Sasaki JE, Tatham TA, and Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology (Berl) 120:303-310.
44. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, and Vanderschuren LJ (2002) Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22:3269-3276.
45. Shoaib M, Zubaran C, and Stolerman IP (2000) Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats. Psychopharmacology 149:140-146.
46. Smith JW and Stolerman IP (2009) Recognising nicotine: the neurobiological basis of nicotine discrimination. Handb Exp Pharmacol 192:295-333.
47. Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed, Iowa State University Press, Ames, IA.
48. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62.
49. Stolerman IP, Chandler CJ, Garcha HS, and Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology (Berl) 129:390-397.
50. Stolerman IP, Garcha HS, and Mirza NR (1995) Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology (Berl) 117:430-437.
51. Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, and Buckley MJ (1994) (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther 271:624-631.
52. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, and Katz JL (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-344.
53. Tidey JW and Bergman J (1998) Drug discrimination in methamphetamine- trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174.
54. Williams MJ and Adinoff B (2008) The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33:1779-1797.
55. Xiao Y and Kellar KJ (2004) The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J Pharmacol Exp Ther 310:98-107.
56. Yasar S, Schindler CW, Thorndike EB, Szelenyi I, and Goldberg SR (1993) Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. J Pharmacol Exp Ther 265:1-6.
57. Zanetti L, Picciotto MR, and Zoli M (2007) Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice. Psychopharmacology (Berl) 190:189-199.